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Abstract 
High variability in infarct size is common in experimental stroke models and affects statistical 
power and validity of neuroprotection trials. The aim of this study was to explore cerebral 
collateral flow as a stratification factor for the prediction of ischemic outcome. Transient 
intraluminal occlusion of the middle cerebral artery (MCA) was induced for 90 minutes in 18 
Wistar rats. Cerebral collateral flow was assessed intra-procedurally using multi-site laser 
Doppler flowmetry (LDF) monitoring in both the lateral MCA territory and the borderzone 
territory between MCA and anterior cerebral artery. Multi-modal magnetic resonance imaging 
was used to assess acute ischemic lesion (diffusion-weighted imaging, DWI), acute perfusion 
deficit (time-to-peak, TTP) and final ischemic lesion at 24 hours. Infarct volumes and typology at 
24 hours (large hemispheric versus basal ganglia infarcts) were predicted by both intra-ischemic 
collateral perfusion and acute DWI lesion volume. Collateral flow assessed by multi-site LDF 
correlated with the corresponding acute perfusion deficit using TTP maps. Multi-site LDF 
monitoring was able to predict ischemic outcome and perfusion deficit in good agreement with 
acute MRI. Our results support the additional value of cerebral collateral flow monitoring for 
outcome prediction in experimental ischemic stroke, especially when acute MRI facilities are not 
available. 
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Introduction 
The failure of promising preclinical neuroprotective therapies to translate into successful clinical 
results raised discussions about the quality of preclinical trials.
1, 2
 Among several aspects, 
attention should be addressed to the poor statistical power of most neuroprotection studies, 
mainly driven by small sample size and variability of lesion size in ischemic models. Several 
factors may account for this variability, including the collateral circulation.
3, 4
 The collateral 
circulation is a subsidiary vascular network virtually able to provide residual perfusion to 
potentially salvageable cerebral regions after occlusion of a cerebral artery.
5
 It is emerging as a 
strong determinant of stroke outcome not only in humans,
6
 but also in experimental stroke 
models.
3, 4
 
In neuroprotection studies, predicting ischemic outcome before animal allocation would allow 
researchers to a priori stratify animals relying on the expected lesion size and to better control 
variability. Multi-modal magnetic resonance imaging (MRI) performed during occlusion has 
previously been used in neuroprotection studies.
7-10
 In particular, a strong correlation between 
acute and 24h ischemic lesion was shown.
11
 
While MRI provides spatial resolution, laser Doppler flowmetry (LDF) instead monitors real-time 
cortical perfusion within a precise cortical region, where a recording probe is positioned. A 
single LDF probe is commonly monitoring in the lateral middle cerebral artery (MCA) territory,
12-
15
 but the perfusion threshold to stratify animals is not well standardized. In the present work, 
two probes were used for the monitoring of cortical perfusion in two different regions:
16
 the 
lateral MCA territory and the borderzone between anterior and middle cerebral arteries (ACA-
MCA) territories, in order to monitor the perfusion drop due to occlusion and the residual 
perfusion provided by the leptomeningeal anastomoses (i.e. collateral circulation), respectively. 
We previously showed a correlation between the collateral perfusion evaluated by multi-site 
LDF and both 24h outcome
3
 and molecular penumbra.
17
 
The aim of this study was to validate the predictive value of collateral flow assessment by multi-
site LDF monitoring in the intraluminal MCA occlusion (MCAO) in rats, using MRI as a 
reference. The transient intraluminal MCA occlusion model in the rat was chosen for this study 
because no craniotomy was required to allow continuous multi-site cerebral hemodynamic 
4 
 
monitoring during ischemia. The results show the additional value of multi-site LDF compared to 
single-site LDF for outcome prediction, suggesting its potential as a good alternative to MRI for 
controlling the variability of lesions. 
 
Materials and Methods 
Animals and experimental design. 
The experimental protocol was approved by the Committee on Animal Care of the University of 
Milano Bicocca Italy, and of the CNRS (CREEA Rhône-Alpes, France, approval n°0274). 
Procedures were performed in accordance with the European Union Directive for animal 
experiments (2010/63/EU), the national guidelines on the use of laboratory animals (D.L. 
116/1992), under project licence from the Italian Ministry of Health and French Decree 2013-118 
and reported according to the ARRIVE (Animals in Research: Reporting In Vivo Experiments) 
guidelines. 
Adult male Wistar Han rats (9-11 weeks old, Charles River Laboratories, L’Arbresle, France) 
were housed at a constant temperature of 22 ± 2°C in Plexiglas cages bedded with wood dust 
in groups of six in a colony room maintained on a 12/12 hours light/dark cycle (07:00–19:00), 
and were provided with food and water ad libitum. A single experimental group of 18 rats (250-
300 g) was considered for this study, where the single animal represents the experimental unit. 
The sample size was estimated based on previous works.
3, 11
 
Experimental design is illustrated in Figure 1-A. On Day 0, animals underwent 90 minutes of 
focal cerebral ischemia induced by intraluminal MCAO. Surgical procedures were performed in 
the morning or afternoon in an equipped surgery room. Cerebral perfusion was monitored by 
multi-site LDF during surgery and occlusion induction. Afterwards, LDF probes were detached 
and animals were immediately transferred to the scanner to undergo multi-parametric MRI (T2-
weighted imaging, diffusion-weighted imaging or DWI and perfusion-weighted imaging or PWI) 
for the respective evaluation of anatomy, acute lesion and perfusion during occlusion. The 
imaging session started approximately 40 minutes after onset of ischemia. After 90 minutes of 
ischemia, animals were reperfused outside the magnet. On Day 1, after 24 hours of reperfusion, 
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neurobehavioral assessment and T2-MRI imaging were performed. Animals were then 
euthanized under deep anesthesia, brains were extracted and the occurrence of any 
subarachnoid hemorrhage, i.e. macroscopic bleeding around the circle of Willis, was evaluated 
ex-vivo. 
The ability of LDF perfusion to predict 24h infarct topology assessed by T2-MRI represents the 
primary outcome. The presence of a correlation between LDF perfusion with acute and 24h 
lesion volumes assessed by MRI (DWI and T2, respectively), with 24h neurobehavioral 
assessment and with acute PWI-MRI parameters represent the secondary outcomes. 
Early death and signs of subarachnoid haemorrhage detected by MRI and ex-vivo evaluation 
were used as exclusion criteria. All investigators were blind to data obtained with other 
modalities than the one they performed and/or analyzed. 
MCAO Surgery. 
On Day 0, rats were anesthetized with 3% isoflurane air, and maintained with 1.5% isoflurane. 
Isofluorane was chosen for the possibility to control the level of anesthesia. Before surgery, 
animals received 0.05 mg/kg subcutaneous buprenorphine to alleviate pain and throughout 
surgical procedure their body temperature was monitored by a rectal thermometer and 
maintained to 37.0±0.5°C by a feedback-controlled heating pad. A silicon-coated filament 
(diameter 0.39±0.02 mm, Doccol Corporation, Redlands, CA, USA) was inserted into the right 
external carotid artery and advanced in the internal carotid artery under multi-site LDF 
monitoring (see below), reaching and occluding the MCA origin. Immediately before filament 
insertion, common carotid artery (CCA) was transiently occluded and subsequently re-opened 
during ischemia and reperfusion. After 90 minutes, the filament was withdrawn and animals 
were allowed to recover and had free access to food and water. 
Multi-site laser Doppler flowmetry. 
An LDF apparatus (dual channel moorVMS-LDF
TM
, Moor, Axminster, UK) was used to 
continuously monitor cerebral perfusion during MCAO surgery, up to occlusion induction and for 
10 minutes after. Two blunt needle probes (VP12, Moor, Axminster, UK) were firmly positioned 
on the intact skull surface thanks to a custom-made silicon probe holder.
16
 The cranial 
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coordinates for probes positioning were based on a rat brain atlas.
18
 A first probe (Probe 1) 
monitored perfusion within the lateral MCA territory, corresponding to the core territory of MCA 
(1 mm posterior to the Bregma and 5 mm lateral to the midline). A second probe (Probe 2) 
monitored perfusion within the borderzone territory between ACA and MCA territory (2 mm 
anterior to the Bregma and 2 mm lateral to the midline), where leptomeningeal anastomoses are 
likely to provide residual perfusion after occlusion induction. For both probes, the residual 
perfusion after occlusion was expressed as % of pre-ischemic baseline. We assessed baseline 
flow as the stable perfusion value in the 5-10 minutes immediately before the occlusion of the 
proximal cerebral arteries (external carotid artery, common carotid artery) in order to avoid the 
confounding effects of anesthesia and surgery. Probes positioning on the skull surface and 
representative LDF recordings are shown in Figure 1-B and C, respectively. 
Magnetic resonance imaging. 
MRI experiments were performed on a Bruker Biospec 7T/12 cm horizontal magnet equipped 
with Paravision 5.0 (Bruker, Ettlingen, Germany). A birdcage head coil of 72 mm inner diameter 
was used for radiofrequency transmission, and a 25 mm-diameter surface coil was used for 
reception. The rats were placed in a cradle equipped with a stereotaxic holder, an integrated 
heating system to maintain body temperature at 37 ± 1°C, and a pressure probe to monitor 
respiration. 
During arterial occlusion, DWI echo planar imaging (EPI) spin-echo images were acquired using 
ﬁeld of view (FOV) = 3.0 x 1.5 cm
2
, fifteen contiguous slices of 1 mm thickness, with matrix = 
128 x 64, echo time/repetition time (TE/TR) = 22.75/5250 ms, and six b-values (100, 200, 400, 
600, 800, 1000 s/mm
2
) for a total duration of 4 minutes 54 s. PWI was performed with multislice 
dynamic susceptibility contrast-enhanced MRI (DSC-MRI), using an EPI gradient-echo 
sequence with the same FOV and slice characteristics, matrix = 80 x 40 and TE/TR 6.61/600 
ms, for a total duration of 1 minute. One hundred consecutive images were acquired per slice 
with a time resolution of 0.6 s during before, during and after the intravenous injection of a 200-
μmol/kg bolus of gadolinium (Dotarem, Guerbet Aulnay-sous-Bois, France). After 24 hours of 
reperfusion, T2-weighted images were acquired using a RARE sequence with the same FOV 
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and slice characteristics, matrix = 256 x 128, effective TE/TR = 60.28/3500 ms, RARE factor 8 
and 4 averages (total duration: 2 minutes 48 s). 
Image analysis. 
Apparent diffusion coefﬁcient (ADC) maps (in mm
2
/s) were calculated by ﬁtting MR signal 
curves to a monoexponential model function on a pixel-by-pixel basis using in-house software 
written in Matlab 2009 (MathWorks, Natick, MA). Time to peak (TTP) maps (in s) were 
calculated after converting the signal-time curves to concentration-time curve according to: 
   
      
 
  
   
    
  
  as the time between the first T2*-weighted measurement and the bolus 
peak.
19
 
Images were analyzed on MIPAV software (Medical Image Processing And Visualization, NIH, 
Bethesda, MD; http://mipav.cit.nih.gov/).
20
 For the evaluation of acute ischemic lesion, the 
ipsilateral regions encompassing hypointense signal (compared to contralateral hemisphere) 
were manually outlined on ADC maps. Subsequently, the acute ischemic lesion was segmented 
in these regions by applying the already reported viability threshold of 0.53x10
-3
 mm
2
/s
21
 and 
lesion volume (expressed in mm
3
) was calculated as the summation of the lesion areas 
multiplied by slice thickness (1 mm). For the evaluation of cerebral perfusion, TTP maps were 
used. Ipsilateral and contralateral ROIs covering the upper cortex were delineated on the two 
slices corresponding to the two regions of LDF monitoring: slice anatomically identified as 
Bregma -1 and Bregma +2, for Probe 1 and Probe 2, respectively. The ipsilateral and 
contralateral average TTP values were considered. Assuming the contralateral perfusion to be 
comparable to pre-ischemic perfusion,
22
 the difference between ipsilateral and contralateral TTP 
values (relative TTP) was considered to reflect the residual perfusion monitored by LDF: 
                       
Where      represents the TTP of ipsilateral cortex and      represent the TTP of contralateral 
cortex. 
24h ischemic outcome evaluation. 
On Day 1, ischemic outcome was evaluted after 24 hours of reperfusion by both 
neurobehavioral testing and T2-weighted MRI for the assessement of infarct volume. 
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Just before Day 1 MRI acquisitions, rats were evaluated for spontaneous activity, motor and 
sensitive function and scored on a scale from 3 (most severe) to 18 (no deficit).
23
 For the 
evaluation of 24h infarct lesion, the ipsilateral areas of hyperintense signal (i.e. ischemic lesion) 
and the ipsilateral and contralateral hemisphere areas were manually defined on T2-weighted 
images. The typology of the ischemic lesions was visually evaluated and animals were 
subsequently divided in two groups: large hemispheric lesions (corticostriatal lesions, Group A) 
and basal ganglia lesions (subcortical lesions, Group B). In addition, infarct areas were 
calculated and corrected for asymmetries due to cerebral edema using the formula
24
 : 
                        
                                           
                           
 
Corrected infarct volume (expressed in mm
3
) was subsequently calculated as the summation of 
the corrected lesion areas multiplied by slice thickness (1 mm).  
Supplementary analyses were performed for the evaluation of the ischemic lesion (See 
Supplementary Material and Methods). Lesion volumes were also calculated and corrected for 
edema according to an alternative formula.
25
 Moreover, histological staining Cresyl violet was 
used as a complementary method for lesion visualization and volume calculation. 
Statistical analysis. 
All results are expressed as mean ± standard deviation, except for neurobehavioral scores 
which are expressed as median [min; max]. Statistical analyses were performed using 
GraphPad Prism software. Unpaired Student’s t-test was used for two-group analysis, while 
correlation and linear regression analysis were computed with Pearson’s r test. Regression 
analyses were not forced through 0. A value of p<0.05 was considered significant. 
Receiver operator curve (ROC) analysis was performed to identify the optimal LDF (i.e. residual 
perfusion) threshold values for the prediction of animals developing a large hemispheric infarct 
at 24 hours (See Supplementary Material and Methods). The area under curve (AUC) was 
considered as an indicator of prediction ability (ranging from 1 = best to 0.5 = worst). 
 
Results 
9 
 
A total number of 18 rats were enrolled in the study. Three rats did not complete the protocol 
because of early death after ischemia, likely due to anesthesiological complications or/and 
massive infarcts. Hence, 15 rats were included in the analysis. No signs of subarachnoid 
haemorrhage were detected by MRI or by ex-vivo evaluation. 
Evaluation of outcome at 24h post-reperfusion. 
Animals with a large hemispheric lesion, characterized by a significant involvement of the 
sensori-motor cortex, were assigned to Group A (n=9, Figure 2-A). Animals with a lesion mainly 
restricted to basal ganglia were assigned to Group B (n=6, Figure 2-B). In Group A, lesion 
volumes (208±61 mm
3
, n=9) were higher than in Group B (68±32 mm
3
, n=6) and no overlap 
was present between the two groups (Figure 2-C). According to these results, Group A animals 
showed higher deficits, resulting in lower neurobehavioral scores (9 [6; 12]) compared to Group 
B (17 [14; 18], n=6) and no overlap between the two groups (Figure 2-D). Similar results were 
obtained with lesion volumes corrected for edema according to an alternative formula
25
 
(Supplementary Figure 1). Excellent matching between histological and T2 images lesion 
visualization and volume is shown in Supplementary Figure 2.   
Diffusion-weighted magnetic resonance imaging for the prediction of ischemic outcome. 
Acute lesion was visually evaluated on ADC maps (Figure 3-A to D) and, as expected, group 
distribution was found to exactly match that of 24h lesion. In other words, animals presenting a 
large hemispheric lesion (or basal ganglia lesion) acute (D0) lesion were presenting a large 
hemispheric lesion (or basal ganglia lesion) 24h (D1) lesion. In addition, acute lesion volume 
quantified on ADC maps positively correlates with 24h lesion volume calculated on T2-weighted 
images (p<0.0001, Pearson’s r 0.91, Figure 3-E). 
 Multi-site laser Doppler flowmetry for the prediction of ischemic outcome. 
Cerebral perfusion was monitored by two probes within two different regions of the ischemic 
cortex: lateral MCA territory (Probe 1) and ACA-MCA borderzone territory (Probe 2). Monitoring 
with Probe 2 encountered technical problems for one rat. This unreliable data was subsequently 
excluded from the analysis. 
10 
 
Residual perfusion values monitored by Probe 1 did not correlate with the 24h ischemic 
outcome, neither in terms of infarct volume (p=0.15, Pearson’s r -0.39, Figure 4-A) nor 
neuroscore (p=0.54, Pearson’s r 0.17, Figure 4-C). In contrast, Probe 2 residual perfusion 
values correlated with 24h ischemic outcome, both for infarct volume (p<0.01, Pearson’s r -0.70, 
Figure 4-B) and neuroscore (p<0.01, Pearson’s r 0.68, Figure 4-D). Furthermore, residual 
perfusion values monitored by Probe 1 did not correlate with the acute lesion volume (p=0.06, 
Pearson’s r -0.51, Figure 4-E), whereas Probe 2 perfusion did (p<0.05, Pearson’s r -0.65, 
Figure 4-F). Similar results were obtained when using an alternative formula for edema 
correction
25
 (Supplementary Figure 1). 
As LDF monitors cortical perfusion, the correlations between residual perfusion values 
monitored by Probe 1 and 2 and the cortical component of acute and 24 hours lesions were 
also explored (Supplementary Figure 3): perfusion from both probes correlated with acute and 
24h cortical infarct volumes, but these correlations were stronger in the case of Probe 2. 
Interestingly, residual perfusion values monitored by Probe 1 were not significantly different 
(p=0.34) between Group A (37%±15%, n=9) and B (46%±17%, n=6) (Figure 5-A). On the 
contrary, residual perfusion values monitored by Probe 2 were significantly higher (p<0.001) in 
Group B (60%±6%, n=6) than in Group A (45%±6%, n=8) (Figure 5-B). In particular, a value of 
53% residual perfusion recorded by Probe 2 was identified by ROC analysis (Supplementary 
Figure 4) as a threshold dividing the two groups with a 100% specificity and 100% sensitivity 
(Supplementary Table 1), with Group A and B presenting lower and higher values, respectively 
(Figure 5-B, dotted line). In contrast, Probe 1 values between the two groups presented a wide 
overlap (Figure 5-A) and a 39% residual perfusion was identified as optimal threshold (i.e. 
maximizing specificity and sensitivity), resulting in 83% specificity and 55% sensitivity 
(Supplementary Table 1). Residual perfusion values recorded by Probe 1 and 2 in the same 
animals were not significantly correlated (p=0.07, Pearson’s r 0.50, Supplementary Figure 5).  
Perfusion-weighted magnetic resonance imaging and laser Doppler flowmetry for the 
evaluation of cerebral perfusion. 
The cortical perfusion was evaluated on TTP maps within slices encompassing the two cortical 
regions of LDF monitoring: slices anatomically identified as Bregma -1 and Bregma +2 for Probe 
11 
 
1 and Probe 2, respectively shown in Figure 6-A and B. TTP values were significantly higher for 
Group A compared to Group B in both Bregma -1 (p<0.05, Figure 6-C) and Bregma +2 (p<0.05, 
Figure 6-D) slices. Interestingly, residual perfusion values monitored by Probe 2 negatively 
correlated with corresponding TTP values (p<0.05, Pearson’s r -0.61, Figure 6-F), whereas 
Probe 1 residual perfusion values did not correlate with corresponding TTP values (p=0.34, 
Pearson’s r -0.27, Figure 6-E). 
 
Discussion 
The aim of this study was to validate collateral flow assessment by multi-site LDF for the 
prediction of the 24-hours ischemic outcome, using multi-modal MRI. Using the intraluminal 
model of 90-minutes MCAO in rats, we observed a variable lesion size after the same surgical 
procedure, as commonly reported by other groups.
26
 The presence or lack of a significant 
cortical involvement (as in large hemispheric and basal ganglia infarcts, respectively) can be 
influenced by exogenous (surgery, filament) and endogenous (collaterals) factors. Outcome 
variability of ischemic stroke models represents one of the several aspects that may participate 
in the translational failure of neuroprotective strategies.
1
 Indeed, variability affects sample 
homogeneity, implying a higher number of animals required to reach an optimal statistical 
power.  
Different methods have been used in experimental stroke research to assess correct MCAO 
induction. i) The presence of neurological deficits during arterial occlusion has been widely used 
in the past as an inclusion criteria, but was shown not predictive of final infarct.
11
 ii) Imaging 
perfusion deficit, acute lesion or vascular occlusion on MRI (PWI-MRI, DWI-MRI and Magnetic 
Resonance Angiography or MRA, respectively) certainly represents the method of choice for the 
prediction of lesion extent,
27
 but it is expensive and not widely available to stroke basic 
scientists. However, the development of benchtop MRI systems could enable a more 
widespread use of imaging in the future.
28
 As disadvantages, MRI requires manipulation of the 
animal during occlusion (accompanied by the risk of thread displacement) and does not provide 
intra-surgical information. iii) LDF has been frequently used to monitor cerebral blood flow drop 
at occlusion induction in several stroke models, including the intraluminal MCA occlusion.
12-15, 29
 
12 
 
This simple and flexible option is probably a method of choice for multicentre neuroprotection 
studies, provided that its application can be standardized. Different perfusion drop values are 
considered to confirm intraluminal MCAO induction, varying in the range of 60-80 %,
12-15, 30
 or 
being not specified.
31
 A single monitoring probe is commonly positioned in the lateral MCA 
territory of the parietal cortical surface, more frequently after craniotomy,
12-15
 while a less 
invasive approach through intact skull may be considered.
16, 30
  
In the present study, multi-site LDF recorded cerebral perfusion in both lateral MCA territory and 
ACA-MCA borderzone (collaterals territory) at MCAO induction, thanks to a custom-made probe 
holder allowing for a precise and stable positioning of two probes over the intact skull surface.
16
 
Although the distance between Probe 1 and Probe 2 is only a few millimeters, our current 
findings and our previously published results
3
 clearly demonstrated that these probes monitor 
two hemodynamically different territories during MCA occlusion: a lateral MCA territory (Probe 
1), which is more densely ischemic after MCA occlusion and receives less collateral flow, and a 
medial MCA territory (Probe 2), which receives more collateral flow (ACA-MCA anastomoses) 
during MCA occlusion. Cerebral perfusion evaluated by LDF in the collaterals territory correlated 
with ischemic outcome after 24 hours of reperfusion, both in terms of infarct volume and 
neuroscore, and acute lesion volumes correlated with 24 hours infarct volumes, confirming our 
previous results.
3, 11
 
Interestingly, different 24h infarct typologies (i.e. large hemispheric or basal ganglia infarcts) 
were correctly a priori identified relying on both visual evaluation of the MRI acute ischemic 
lesion and LDF perfusion monitored in the collaterals territory (but not in the lateral MCA 
territory). Indeed, the best predictive value was provided by Probe 2 (AUC=1), versus a weaker 
predictive value provided by Probe 1 (AUC=0.66) (See Supplementary Figure 4). Accordingly, a 
53% residual perfusion recorded by Probe 2 was identified as a threshold associated with 100% 
specificity and 100% sensitivity, i.e. complete and correct segregation of infarct types. A 39% 
residual perfusion was identified as the optimal threshold (i.e. maximizing the specificity and 
sensitivity) for Probe 1, associated with 83% specificity and 56% sensitivity. The 39% perfusion 
threshold value obtained for Probe 1 is in the range of values reported in the literature for the 
prediction of large hemispheric infarcts (i.e. <40-20% residual perfusion). Of note, if this 
13 
 
threshold had been applied for animal stratification in our study, one animal with a basal ganglia 
infarct (false positive) would have been wrongly included, and four animals with large 
hemispheric infarct (false negative) would have been wrongly excluded. This misclassification 
would have a strong impact in a neuroprotection study. 
In order to confirm that LDF perfusion monitored in a restricted cortical area is reflecting the 
actual perfusion, the latter was evaluated on TTP maps computed from per-occlusion PWI-MRI 
and compared to LDF perfusion. In other words, the correlation between LDF and MRI perfusion 
was used as a surrogate for LDF reliability. As expected, cortical perfusion was significantly 
lower for the large hemispheric compared to basal ganglia infarcts, in both slices corresponding 
to Probe 1 and Probe 2 monitoring sites (Bregma -1 and Bregma +2, respectively). Notably, 
TTP values correlated with LDF perfusion only for Probe 2 and not for Probe 1, suggesting a 
weaker reliability of Probe 1 compared to Probe 2.  
The current assumption is that perfusion recorded by Probe 1 results from the drop in perfusion 
in the MCA core territory. Nonetheless, we cannot exclude that the perfusion recorded by Probe 
1 might also be influenced by the posterior collateral perfusion (i.e. leptomeningeal 
anastomoses between the posterior and the middle cerebral artery). In addition, a monitoring 
bias might have been introduced by probe placement in the vicinity of a major arterial vessel, 
This event is more likely to happen in Probe 1 area (located close to MCA branches, where 
macrocirculation predominates) rather than in Probe 2 area (located in the borderzone ACA-
MCA territory, where microcirculation predominates). Therefore, a “contamination” of Probe 1 
recording might have occurred in some animals and may at least partially explain the larger 
scatter of Probe 1 values compared to Probe 2, and the lack of correlation between TTP and 
LDF values for this same probe. Although both probes are likely to be correlated at a 
populational level (see Supplementary Figure 5), our results clearly demonstrate a stronger 
predictive ability for Probe 2 compared Probe 1 at an individual level (See supplementary Table 
1). Our hypothesis is that cortical involvement is mainly determined by the extent of collateral 
flow, hence the advantage of monitoring this parameter (with Probe 2) in addition to the 
perfusion drop in the core territory of the MCA (with Probe 1). 
14 
 
A major limitation of this study is the small sample size. Nevertheless, we were able to obtain 
reliable stratification based on Probe 2 perfusion value despite n=15. On the other hand, if a 
higher sample size was considered, Probe 2 perfusion values would certainly overlap between 
groups A and B. Indeed, perfusion values of both groups were close to the 53% perfusion 
threshold for Probe 2, with subsequent wide 95% IC of both sensitivity and specificity values 
(see Supplementary Table 1). Further studies in independent laboratories including larger 
sample size are necessary to confirm the efficiency of multi-site LDF stratification. Generally, in 
order to apply multi-site LDF to a larger experimental stroke study, we would suggest 
researchers to perform a pilot study for the identification of the optimal perfusion drop threshold 
in their own experimental setting, which can be defined as that maximizing specificity and 
sensitivity in case of uncomplete separation of the two groups (see Supplementary Figure 4). 
Alternatively, the complete exclusion of false positives might represent the priority over the 
exclusion of false negative: if a basal ganglia infarct is a priori misclassified as large 
hemispheric infarct (i.e. false positive) and subsequently allocated in a treatment group, its small 
volume on follow-up will be wrongly interpreted as a result of the neuroprotective effect. In an 
attempt to minimize false positives, the threshold value associated with the highest specificity 
should be identified. Nonetheless, if on the one hand the exclusion of animals would reduce 
variability, on the other the number of animals required for a neuroprotection study would 
increase. In order to avoid this drawback, the additional information provided by monitoring 
collateral flow could also be  used to evaluate a potential confounding effect resulting from a 
differential pre-treatment cerebral perfusion between experimental groups: if a treatment effect 
is observed, but a better pre-treatment collateral perfusion is monitored in a treatment group 
compared to control group, the positive treatment results should be interpreted with care. 
Otherwise, if pre-treatment collateral perfusion is comparable in treatment and control groups, 
the pre-treatment variability of ACA-MCA collateral flow is unlikely to have confounded results.   
Another limitation is represented by the lack of simultaneous assessment of multi-site LDF and 
MRI, which would have required amagnetic LDF probes and compatible surface head coils.  As 
a consequence, LDF perfusion monitoring was not performed during the whole period of 
ischemia, including reperfusion. However, our previously published results showed stable LDF 
signal during intraluminal MCAO over 60 minutes
3
 and 90 minutes,
17
 and successful reperfusion 
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in all animals in both studies (n=20 and n=25, respectively). In neuroprotection studies, multi-
site LDF could be used to continuously monitor perfusion, helping in identifying any animals with 
delayed or no reperfusion. Of note, a recent work in mice showed that ADC lesion volumes 
during MCAO predicted final infarct volumes for 90-minutes MCAO, but not for 45-minutes 
MCAO,
32
 thus further investigation in future studies should evaluate the predictive value of LDF 
for different occlusion durations. 
In summary, multi-site LDF for the monitoring of collateral flow was in agreement with multi-
modal acute MRI for the prediction of ischemic outcome in experimental ischemic stroke. We 
propose this approach to a priori stratify animals in neuroprotection studies, in order to enhance 
sample homogeneity and contribute to the refinement and eventual reduction of the use of 
animals in research. The additional value of multi-site LDF compared to single-site LDF 
highlights its potential for outcome prediction in experimental ischemic stroke, especially for 
laboratories in which MRI is not accessible. 
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Figures 
 
Figure 1. Experimental design and LDF monitoring. A. On Day 0, animals (n=18) underwent 90 
minutes of focal cerebral ischemia induced by intraluminal MCAO. Cerebral perfusion was 
monitored by multi-site LDF during surgery up to occlusion induction and for 10 minutes after. 
Next, animals underwent multi-parametric MRI, including DWI and PWI for the respective 
evaluation of acute lesion and perfusion during occlusion. After 90 minutes of ischemia, animals 
were reperfused. On Day 1, after 24 hours of reperfusion, neurobehavioral assessment and T2-
MRI imaging were performed. B. Probes position on the skull surface is shown. C. 
Representative LDF tracings are shown for Probe 1 (upper tracing) and 2 (lower tracing), 
baseline flow and perfusion deficit after MCAO are indicated (shaded portions). MCAO = middle 
cerebral artery occlusion; LDF = laser Doppler flowmetry; MRI = magnetic resonance imaging; 
DWI = diffusion-weighted imaging; PWI = perfusion-weighted imaging; ADC = apparent diffusion 
coefﬁcient; TTP = time-to-peak. 
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Figure 2. Evaluation of post-reperfusion ischemic outcome. Representative T2-weighted 
images showing a large hemispheric (A) and basal ganglia (B) lesion, visible as hyperintense 
areas (contoured). C. Ischemic lesion volumes of Group A were higher compared to Group B 
and no overlap was present between the two groups (dot-dashed line). D. Neurobehavioral 
scores in Group A were lower (higher deficit) compared to Group B and no overlap was present 
between the two groups (dot-dashed line). Black spots = Group A animals (n=9); White spots = 
Group B animals (n=6).  
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Figure 3. Evaluation of acute ischemic lesion on DWI-MRI and correlation with 24 hours 
ischemic lesion. Representative ADC maps showing a large hemispheric (A) and basal ganglia 
(C) lesion, visible as hypointense areas (same animals as in Figure 2). Corresponding 
segmentation masks of the lesion (viability threshold value 0.53 x 10
-3 
mm
2
/s) are superimposed 
on the ADC maps (B and D). E. Acute lesion volumes positively correlate with 24h lesion 
volumes, with a slope of 1.11±0.14. Dotted lines represent the 95% confidence interval of the 
regression line. Black spots = Group A animals (n=9); White spots = Group B animals (n=6). 
DWI = diffusion-weighted imaging; MRI = magnetic resonance imaging; ADC = apparent 
diffusion coefﬁcient. 
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Figure 4. Multi-site LDF perfusion monitoring and correlation with acute lesion and 24h 
ischemic outcome. No significant correlation was observed between Probe 1 perfusion values 
and 24h ischemic outcome, neither in terms of ischemic lesion volumes (A) and neuroscores 
(C), nor acute lesion volumes (E). In contrast, a negative correlation was observed between 
Probe 2 perfusion values and both 24h ischemic outcome, in terms of ischemic lesion volumes 
(B) and neuroscores (D), and acute lesion volumes (F). The 53% perfusion value threshold 
discriminating between group A and B in shown in B and D (dot-dashed line). Dotted lines 
represent the 95% confidence interval of the regression line. Black spots = Group A animals 
(n=9 in A, C and E; n=8 in B, D and F); White spots = Group B animals (n=6). The arrowhead 
in F indicates two overlapped spots. LDF = laser Doppler flowmetry. 
 
26 
 
 
Figure 5. Multi-site LDF perfusion monitoring and infarct typology classification. A. Group A  
and B  perfusion values monitored by Probe 1 are not significantly different and are largely 
overlapping. B. Group A  and B  perfusion values monitored by Probe 2 are significantly 
different and a 53% value was identified as a threshold discriminating between the two groups 
(dot-dashed line). Black spots = Group A animals (n=9 in A; n=8 in B); White spots = Group B 
animals (n=6). *** p<0.001. LDF = laser Doppler flowmetry. 
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Figure 6. Cerebral perfusion evaluated by PWI-MRI and multi-site LDF. A and B. Ipsilateral and 
contralateral TTP values measured within cortical ROIs delineated on the two slices 
corresponding to the two regions of LDF monitoring: slice anatomically identified as Bregma -1 
(A) and Bregma +2 (B), for Probe 1 and Probe 2, respectively (yellow, left hemisphere: 
contralateral ROI; red, right hemisphere: ipsilateral ROI). Relative TTP values (delay of bolus 
peak between the contralateral and ipsilateral hemisphere) were significantly different between 
Group A and B for both slice Bregma -1 (Probe 1 position) (C) and Bregma +2 (Probe 2 
position) (D). E. No significant correlation was observed between Probe 1 residual perfusion 
values and corresponding TTP values. F. A negative correlation was observed between Probe 2 
residual perfusion values and corresponding TTP values. Dotted lines represent the 95% 
confidence interval of the regression line. Black spots = Group A animals (n=9); White spots = 
Group B animals (n=6). * p<0.05. LDF = laser Doppler flowmetry; PWI = perfusion-weighted 
imaging; MRI = magnetic resonance imaging; TTP = time-to-peak. 
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Supplementary Materials and Methods 
Edema correction by Gerriets and colleagues, 2004. 
Infarct volumes measured at 24 hours were corrected with an alternative edema correction, 
according to the formula provided by Gerriets and colleagues:
1
 
                       
   
       
     
  
Where     and     represent the corrected and uncorrected lesion volume, respectively, and 
    and     represent the contralateral and ipsilateral hemispheres volume, respectively. For 
this purpose, the ipsilateral lesion areas, and the ipsilateral and contralateral hemisphere areas 
were manually defined on T2-weighted images using MIPAV software (Medical Image 
Processing And Visualization, NIH, Bethesda, MD; http://mipav.cit.nih.gov/).2 Subsequently, 
   ,    , and   
  (expressed in mm
3
) where calculated as the summation of the slice thickness 
(1 mm) multiplied by the ipsilateral hemispheric, contralateral hemispheric, and ipsilateral lesion 
areas, respectively.  
Unpaired Student’s t-test was used for two-group analysis, while correlation and linear 
regression analysis were computed with Pearson’s r test. Regression analysis were not forced 
through 0. A value of p<0.05 was considered significant. 
Cerebral tissue processing and Cresyl violet staining. 
After animals were euthanized under deep anesthesia, brains were post-fixed by immersion in 
10% formaldehyde for at least 24 hours, and coronal sections (50 μm thick) were cut on a 
vibratome. A number of 19 consecutive sections (250 μm interval) were stained with Cresyl 
violet (Bioptica, Milano, Italy). A digital camera (Nikon Coolpix P5000) adaptable to a 
stereomicroscope was used to obtain images of each section. Ischemic lesion, ipsilateral, and 
contralateral hemisphere areas where manually delineated using ImageJ image processing 
software (National Institute of Health, Bethesda, MD, USA). In order to correct the infarct 
volume for asymmetries due to cerebral edema, the lesion areas were corrected using the 
formula from Leach and colleagues:
3
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Corrected infarct volume (expressed in mm
3
) was subsequently calculated as the summation of 
the corrected lesion areas multiplied by slice thickness (1 mm).  
Correlation and linear regression analysis were computed with Pearson’s r test. Regression 
analysis was not forced through 0. A value of p<0.05 was considered significant. 
Receiver-operator curve analysis. 
Receiver operator curve (ROC) analysis was performed to identify the optimal LDF (i.e. residual 
perfusion) threshold values for the prediction of animals developing a large hemispheric infarct 
at 24 hours. Threshold values maximizing specificity and sensitivity were identified and defined 
as optimal. The area under curve (AUC) was considered as an indicator of prediction ability 
(ranging from 1 = best to 0.5 = worst). The positive predictive value (PPV, the probability that 
animals predicted to develop a large hemispheric infarct, had a large hemispheric infarct at 24 
hours) and negative predictive value (NPV, the probability that animals predicted to develop a 
basal ganglia infarct, had a basal ganglia infarct at 24 hours) were calculated as: 
         
  
       
     
         
  
       
     
Where    represents the number of true positives, i.e. animals predicted to develop a large 
hemispheric infarct, and who actually developed large hemispheric infarct at 24h;    represents 
the number of false positives, animals predicted to develop a large hemispheric infarct, and who 
instead developed basal ganglia infarct at 24h;    represents the number of true negatives, i.e. 
animals predicted to develop a basal ganglia infarct, and who actually developed a basal 
ganglia infarct at 24h;    represents the number of false negatives, i.e. animals predicted to 
develop a basal ganglia infarct, and who instead developed a large hemispheric infarct at 24h.  
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Supplementary Figures 
 
Supplementary Figure 1. Analysis for infarct volumes calculated with an alternative edema 
correction (Gerriets et al., 2004). A. Ischemic lesion volumes of Group A were significantly 
higher compared to Group B and a slight overlap was present between the two groups. B. Acute 
lesion volumes positively correlate with 24h lesion volumes, with a slope of 1.02 ± 0.15. C. No 
significant correlation was observed between Probe 1 perfusion values and 24h lesion volumes. 
D. A negative correlation was observed between Probe 2 perfusion values and both 24h lesion 
volumes. The 53% perfusion value threshold discriminating between group A and B in shown in 
D (dot-dashed line). Dotted lines represent the 95% confidence interval of the regression line. 
Black spots = Group A animals (n=9 in A, B and C; n=8 in D); White spots = Group B animals 
(n=6). *** p<0.001. 
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Supplementary Figure 2. Infarct lesion and volume evaluation on cerebral tissue sections 
stained with Cresyl violet (CV) and comparison with T2-images. Large hemispheric (A) and 
basal ganglia (B) infarcts visualized on T2 images and corresponding tissue sections stained 
with Cresyl violet. C. A strong positive correlation is present between infarct volumes calculated 
with the two methods. Dotted lines represent the 95% confidence interval of the regression line. 
Black spots = Group A animals (n=9); White spots = Group B animals (n=6). 
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Supplementary Figure 3. Multi-site LDF perfusion monitoring and correlation with 24h and 
acute cortical lesion volumes. A significant negative correlation was observed between LDF 
perfusion values recorded by Probe 1 and 24h (A) and acute (C) cortical lesion volumes. A 
stronger significant negative correlation was observed between LDF perfusion values recorded 
by Probe 2 and 24h (B) and acute (D) cortical lesion volumes. The 53% perfusion value 
threshold discriminating between group A and B in shown in B (dot-dashed line). Dotted lines 
represent the 95% confidence interval of the regression line. Black spots = Group A animals 
(n=9 in A and C; n=8 in B and D); White spots = Group B animals (n=6). LDF = laser Doppler 
flowmetry. 
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Supplementary Figure 4. ROC curves for the identification of large hemispheric infarcts for 
LDF residual perfusion for Probe 1 and 2. Values maximizing specificity and sensitivity for our 
study were identified: <39% residual perfusion for Probe 1 (white harrow) and <53% residual 
perfusion for Probe 2 (black arrow). AUC values for ROC curves were: 0.66 (for Probe 1) and 1 
(for Probe 2). LDF = laser Doppler flowmetry; AUC = area under curve. 
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Supplementary Figure 5. No significant correlation was observed between Probe 1 and Probe 
2 perfusion values monitored in the same animals. Black spots = Group A animals (n=8); White 
spots = Group B animals (n=6). *** p<0.001. LDF = laser Doppler flowmetry. 
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Supplementary Table 
 
Optimal 
Threshold 
TP TN FP FN 
Specificity 
(95% IC) 
Sensitivity 
(95% IC) 
PPV NPV 
(n/total) (%) 
LDF 
Probe 1 <39% 5/15 5/15 1/15 4/15 83 (36-100) 56 (21-86) 83 56 
Probe 2 <53% 8/14 6/14 0/14 0/14 100 (54-100) 100 (63-100) 100 100 
 
Supplementary Table 1. Optimal thresholds for the prediction of large hemispheric infarcts for 
LDF residual perfusion for Probe 1 and 2 and related: true positive/negative and false 
positive/negative numbers, specificity (95% IC), sensitivity (95% IC), and positive/negative 
predictive values. Values maximizing specificity and sensitivity were identified on ROC curves 
and considered as optimal threshold values. LDF = laser Doppler flowmetry; TP = true positive; 
TN = true negative; FP = false positive; FN = false negative; PPV = positive predictive value; 
NPV = negative predictive value. 
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